Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate Cancer (English)
- New search for: Jeet, V.
- New search for: J. Russell, P.
- New search for: D. Verma, N.
- New search for: Khatri, A.
- New search for: Jeet, V.
- New search for: J. Russell, P.
- New search for: D. Verma, N.
- New search for: Khatri, A.
In:
Current Cancer Drug Targets
;
12
, 2
;
144-163
;
2012
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate Cancer
-
Additional title:CCDT
-
Contributors:
-
Published in:Current Cancer Drug Targets ; 12, 2 ; 144-163
-
Publisher:
- New search for: Bentham Science Publishers Ltd.
-
Publication date:2012-03-01
-
Size:20 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:Aurora kinases , Cancer , chemotherapy , combination therapy , docetaxel , prostate cancer , targeted molecular therapy , Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) , Androgen Sensitive , Androgen Depletion Independent , Combination Index , Dose Reduction Index , Horse Radish Peroxidase , Harris' Hematoxylin and Eosin , Inner Centromere Protein , Oncology
-
Source:
Table of contents – Volume 12, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 85
-
The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer DrugsA. Stivala, L. / Cazzalini, O. / Prosperi, E. et al. | 2012
- 97
-
Gamma-Amino Butyric Acid Inhibits the Nicotine-Imposed Stimulatory Challenge in Xenograft Models of Non-Small Cell Lung CarcinomaA.N. Al-Wadei, H. / H. Al-Wadei, M. / F. Ullah, M. / M. Schuller, H. et al. | 2012
- 107
-
Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung CancerA. Kono, S. / E. Heasley, L. / C. Doebele, R. / R. Camidge, D. et al. | 2012
- 124
-
Analysis of the Concordance in the EGFR Pathway Status Between Primary Tumors and Related Metastases of Colorectal Cancer Patients:Implications for Cancer TherapyCejas, P. / Lopez-Gomez, M. / Aguayo, C. / Madero, R. / Moreno-Rubio, J. / de Castro Carpeno, J. / Belda-Iniesta, C. / Barriuso, J. / Moreno Garcia, V. / Diaz, E. et al. | 2012
- 132
-
Characterization of the Prostaglandin E2 Pathway in a Rat Model of Esophageal AdenocarcinomaPiazuelo, E. / Santander, S. / Cebrian, C. / Jimenez, P. / Pastor, C. / A. Garcia-Gonzalez, M. / Esteva, F. / Esquivias, P. / Ortego, J. / Lanas, A. et al. | 2012
- 144
-
Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate CancerJeet, V. / J. Russell, P. / D. Verma, N. / Khatri, A. et al. | 2012
- 164
-
Transplacental Antioxidants Inhibit Lung Tumors in Mice Exposed to Cigarette Smoke After Birth: A Novel Preventative Strategy?Balansky, R. / Ganchev, G. / Iltcheva, M. / E. Steele, V. / De Flora, S. et al. | 2012
- 170
-
Anticancer Drugs Aimed at E6 and E7 Activity in HPV-Positive Cervical CancerTan, S. / G.E. de Vries, E. / G.J. van der Zee, A. / de Jong, S. et al. | 2012